Design Therapeutics DSGN
NASDAQ DSGN
$10.77 +0.12 (+1.08%)
As of: Nov 11, 2026 · 3:01 PM EST

Design Therapeutics (DSGN) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Design Therapeutics' Return on Capital Employed [ROCE] was -37.52% in Q2 2026, down 3.68 percentage points from -33.84% a year earlier and down 1.41 percentage points from the prior quarter.

Analysis

Design Therapeutics (DSGN) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Design Therapeutics came in at -35.15%, down 11.37 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a four-year change of -17.94 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -23.77% in FY2024 (+1.80 pp), -25.57% in FY2023 (-6.54 pp), -19.04% in FY2022 (-1.83 pp) and -17.21% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has moved between -38.59% (Q4 2025) and -7.19% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has declined for six straight quarters, with an average year-over-year change of -5.66 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2024 (a gain of 4.56 percentage points); the worst was Q3 2025 (a drop of 14.28 percentage points).
  • Per Business Quant data, DSGN's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -36.10% (Q1 2026), -38.59% (Q4 2025) and -37.83% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Design Therapeutics 679.31 Mn -179.36 Mn - -40.49%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -40.49%
Jun 30, 2026 -37.52%
Mar 31, 2026 -36.10%
Dec 31, 2025 -38.59%
Sep 30, 2025 -37.83%
Jun 30, 2025 -33.84%
Mar 31, 2025 -28.92%
Dec 31, 2024 -25.11%
Sep 30, 2024 -23.55%
Jun 30, 2024 -23.67%
Mar 31, 2024 -25.60%
Dec 31, 2023 -27.42%
Sep 30, 2023 -28.11%
Jun 30, 2023 -27.06%
Mar 31, 2023 -23.43%
Dec 31, 2022 -20.05%
Sep 30, 2022 -16.91%
Jun 30, 2022 -14.06%
Mar 31, 2022 -11.48%
Dec 31, 2021 -9.18%
API Access

Design Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DSGN&period=max&api_key=YOUR_API_KEY